$OVTZ
OCULUS VISIONTECH INC.

2022 Q4 Form 10-Q Financial Statement

#000143774922025922 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $193.9K $116.2K $113.6K
YoY Change -32.73% 2.25% 35.89%
% of Gross Profit
Research & Development $225.0K $283.3K $295.8K
YoY Change -7.13% -4.25% 217.18%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $418.9K $399.4K $409.4K
YoY Change -21.04% -2.44% 131.48%
Operating Profit -$578.8K
YoY Change 94.9%
Interest Expense $5.150K $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $400.00 -$524.7K -$578.8K
YoY Change -100.08% -9.35% 94.91%
Income Tax
% Of Pretax Income
Net Earnings $400.00 -$524.7K -$578.8K
YoY Change -100.08% -9.35% 94.9%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share $0.00 -$5.739K -$6.331K
COMMON SHARES
Basic Shares Outstanding 91.42M 91.42M 91.42M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $687.6K $1.020M $2.707M
YoY Change -68.87% -62.32% 288.98%
Cash & Equivalents $687.6K $1.020M $2.707M
Short-Term Investments
Other Short-Term Assets $28.03K $13.57K $2.400K
YoY Change -0.39% 465.42% -48.83%
Inventory
Prepaid Expenses $28.03K $13.57K $2.403K
Receivables
Other Receivables
Total Short-Term Assets $717.8K $1.043M $2.716M
YoY Change -68.04% -61.6% 287.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $1.00 $2.00
YoY Change -100.0% -50.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $717.8K $1.043M $2.716M
Total Long-Term Assets $0.00 $1.00 $2.00
Total Assets $717.8K $1.043M $2.716M
YoY Change -68.04% -61.6% 1.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $224.7K $229.5K $60.00K
YoY Change 263.41% 282.56% 18.55%
Accrued Expenses $51.87K $24.73K $49.08K
YoY Change 50.96% -49.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $302.4K $279.7K $244.8K
YoY Change 146.63% 14.25% 31.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $302.4K $279.7K $244.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $302.4K $279.7K $244.8K
YoY Change 146.63% 14.25% 31.56%
SHAREHOLDERS EQUITY
Retained Earnings -$47.80M -$47.80M -$45.62M
YoY Change 3.57% 4.78% 9.02%
Common Stock $46.85M $46.85M $47.67M
YoY Change 0.0% -1.72% 8.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $415.4K $763.4K $2.471M
YoY Change
Total Liabilities & Shareholders Equity $717.8K $1.043M $2.716M
YoY Change -68.04% -61.6% 1.83%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $400.00 -$524.7K -$578.8K
YoY Change -100.08% -9.35% 94.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$343.2K -$381.3K -$356.3K
YoY Change -31.95% 7.01% 105.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.150K $0.00
YoY Change
Cash From Investing Activities $5.150K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -343.2K -381.3K -356.3K
Cash From Investing Activities 5.150K 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -338.1K -381.3K -356.3K
YoY Change -32.97% 7.01% 105.27%
FREE CASH FLOW
Cash From Operating Activities -$343.2K -$381.3K -$356.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91422569
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1019957 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2208451 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23154 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91422569
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37832 usd
CY2022Q3 us-gaap Assets
Assets
1043111 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91422569
CY2021Q4 us-gaap Assets
Assets
2246283 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
254268 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91422569
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
96198 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
25471 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91422569
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
26425 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
279739 usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29651
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
122623 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1576391
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
46850710 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 507 - 837 West Hastings Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3N6
dei City Area Code
CityAreaCode
604
dei Local Phone Number
LocalPhoneNumber
685-1017
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
46850710 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1334584 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
998477 usd
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
414128 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
414128 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-40219 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6190 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47795831 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46145845 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
763372 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2123660 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1043111 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2246283 usd
CY2022Q3 ovtz Consulting Expense
ConsultingExpense
45000 usd
CY2021Q3 ovtz Consulting Expense
ConsultingExpense
0 usd
ovtz Consulting Expense
ConsultingExpense
90000 usd
ovtz Consulting Expense
ConsultingExpense
24021 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
283269 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
295830 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
912892 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
575999 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
116163 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
113607 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
310987 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
319132 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80267 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169373 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
336107 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
537019 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
524699 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
578810 usd
us-gaap Costs And Expenses
CostsAndExpenses
1649986 usd
us-gaap Costs And Expenses
CostsAndExpenses
1456171 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-524699 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-578810 usd
us-gaap Net Income Loss
NetIncomeLoss
-1649986 usd
us-gaap Net Income Loss
NetIncomeLoss
-1456171 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22525 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-46409 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-547224 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-578810 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1696395 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1456171 usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91422569
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91422569
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91422569
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89476981
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2123660 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
336107 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-46409 usd
us-gaap Net Income Loss
NetIncomeLoss
-1649986 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
763372 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1230329 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
80267 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-22525 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-524699 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
763372 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328205 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3098616 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
36370 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
537019 usd
us-gaap Net Income Loss
NetIncomeLoss
-1456171 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2471299 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2880736 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
169373 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-578810 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2471299 usd
us-gaap Net Income Loss
NetIncomeLoss
-1649986 usd
us-gaap Net Income Loss
NetIncomeLoss
-1456171 usd
us-gaap Share Based Compensation
ShareBasedCompensation
336107 usd
us-gaap Share Based Compensation
ShareBasedCompensation
537019 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14678 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3400 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
158070 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
76755 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
21 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1141131 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-845776 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3098616 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
36370 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3062246 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-47363 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1188494 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2216470 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2208451 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
490190 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1019957 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2706660 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q3 ovtz Common Stock Shares Held In Escrow
CommonStockSharesHeldInEscrow
5175000
us-gaap Net Income Loss
NetIncomeLoss
-1649986 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1986665 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2772484 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47795831 usd
CY2022Q3 ovtz Working Capital Deficit
WorkingCapitalDeficit
763372 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Significant judgments, estimates and assumptions</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are <em style="font: inherit;">not</em> limited to the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><span style="text-decoration: underline; ">Significant judgments</span></p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 27pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the determination of functional currencies</p></td></tr> </tbody></table>
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12500000
CY2020Q4 ovtz Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.001
ovtz Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
4900000
ovtz Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice
1.00
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17400000
CY2021Q3 ovtz Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.28
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17400000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13572 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28141 usd
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9582 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9691 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23154 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37832 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
229537 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
61836 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
24731 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
34362 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
254268 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
96198 usd
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91422569
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91422569
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3850000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.36
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3363000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1465000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.86
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5315000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.49
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3910950 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5415000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.50
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5415000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3618000
CY2022Q3 ovtz Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
4900000
ovtz Filing And Regulatory Fee
FilingAndRegulatoryFee
34280 usd
ovtz Filing And Regulatory Fee
FilingAndRegulatoryFee
26731 usd
us-gaap Marketing Expense
MarketingExpense
73053 usd
us-gaap Marketing Expense
MarketingExpense
31374 usd
us-gaap Professional Fees
ProfessionalFees
67882 usd
us-gaap Professional Fees
ProfessionalFees
102870 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
28809 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
29857 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106963 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
128300 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
310987 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
319132 usd
ovtz Research And Development Expense Project Management
ResearchAndDevelopmentExpenseProjectManagement
11990 usd
ovtz Research And Development Expense Project Management
ResearchAndDevelopmentExpenseProjectManagement
108000 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
677035 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
403629 usd
ovtz Research And Development Expense Business Development
ResearchAndDevelopmentExpenseBusinessDevelopment
99636 usd
ovtz Research And Development Expense Business Development
ResearchAndDevelopmentExpenseBusinessDevelopment
43000 usd
ovtz Research And Development Expense Payroll
ResearchAndDevelopmentExpensePayroll
124231 usd
ovtz Research And Development Expense Payroll
ResearchAndDevelopmentExpensePayroll
21370 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
912892 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
575999 usd
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
196503 usd
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
176171 usd

Files In Submission

Name View Source Status
0001437749-22-025922-index-headers.html Edgar Link pending
0001437749-22-025922-index.html Edgar Link pending
0001437749-22-025922.txt Edgar Link pending
0001437749-22-025922-xbrl.zip Edgar Link pending
ex_440300.htm Edgar Link pending
ex_440301.htm Edgar Link pending
ex_440302.htm Edgar Link pending
ex_440303.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
ovtz-20220930.xsd Edgar Link pending
ovtz20220930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ovtz-20220930_cal.xml Edgar Link unprocessable
ovtz-20220930_def.xml Edgar Link unprocessable
ovtz-20220930_pre.xml Edgar Link unprocessable
ovtz-20220930_lab.xml Edgar Link unprocessable
ovtz20220930_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending